TargetVasopressin V2 receptor(Rattus norvegicus (Rat))
Central Pharmaceutical Research Institute
Curated by ChEMBL
Central Pharmaceutical Research Institute
Curated by ChEMBL
Affinity DataIC50: <1nMAssay Description:Inhibitory activity against arginine vasopressin V2 receptor using [3H]AVP as radioligand in rat adrenal medullaMore data for this Ligand-Target Pair
TargetVasopressin V2 receptor(Homo sapiens (Human))
Central Pharmaceutical Research Institute
Curated by ChEMBL
Central Pharmaceutical Research Institute
Curated by ChEMBL
Affinity DataIC50: 1nMAssay Description:Inhibitory activity against human recombinant arginine vasopressin V2 receptor using [3H]-AVP as radioligand in CHO cellsMore data for this Ligand-Target Pair
TargetVasopressin V2 receptor(Rattus norvegicus (Rat))
Central Pharmaceutical Research Institute
Curated by ChEMBL
Central Pharmaceutical Research Institute
Curated by ChEMBL
Affinity DataIC50: 1nMAssay Description:Inhibitory activity against arginine vasopressin V2 receptor using [3H]-AVP as radioligand in rat adrenal medullaMore data for this Ligand-Target Pair
TargetVasopressin V1a/V1b receptor(Homo sapiens (Human))
Central Pharmaceutical Research Institute
Curated by ChEMBL
Central Pharmaceutical Research Institute
Curated by ChEMBL
Affinity DataIC50: <1nMAssay Description:Inhibitory activity against arginine vasopressin V1 receptor using [3H]AVP as radioligand in human plateletMore data for this Ligand-Target Pair
TargetVasopressin V2 receptor(Homo sapiens (Human))
Central Pharmaceutical Research Institute
Curated by ChEMBL
Central Pharmaceutical Research Institute
Curated by ChEMBL
Affinity DataIC50: 2nMAssay Description:Inhibitory activity against human recombinant arginine vasopressin V2 receptor using [3H]-AVP as radioligand in CHO cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 2nMAssay Description:Inhibitory activity against arginine vasopressin V1 receptor using [3H]AVP as radioligand in rat liverMore data for this Ligand-Target Pair
Affinity DataIC50: 3nMAssay Description:Inhibitory activity against arginine vasopressin V1 receptor using [3H]AVP as radioligand in rat liverMore data for this Ligand-Target Pair
TargetVasopressin V2 receptor(Rattus norvegicus (Rat))
Central Pharmaceutical Research Institute
Curated by ChEMBL
Central Pharmaceutical Research Institute
Curated by ChEMBL
Affinity DataIC50: 3nMAssay Description:Inhibitory activity against arginine vasopressin V2 receptor using [3H]-AVP as radioligand in rat adrenal medullaMore data for this Ligand-Target Pair
TargetVasopressin V2 receptor(Rattus norvegicus (Rat))
Central Pharmaceutical Research Institute
Curated by ChEMBL
Central Pharmaceutical Research Institute
Curated by ChEMBL
Affinity DataIC50: 3nMAssay Description:Inhibitory activity against arginine vasopressin V2 receptor using [3H]-AVP as radioligand in rat adrenal medullaMore data for this Ligand-Target Pair
TargetVasopressin V1a/V1b receptor(Homo sapiens (Human))
Central Pharmaceutical Research Institute
Curated by ChEMBL
Central Pharmaceutical Research Institute
Curated by ChEMBL
Affinity DataIC50: 3nMAssay Description:Inhibitory activity against arginine vasopressin V1 receptor using [3H]AVP as radioligand in human plateletMore data for this Ligand-Target Pair
TargetVirion infectivity factor(Human immunodeficiency virus type 1 group M subtyp...)
Japan Tobacco
US Patent
Japan Tobacco
US Patent
Affinity DataIC50: 3.40nMT: 2°CAssay Description:The donor DNA was diluted with TE buffer to 20 nM, of which 50 μL was added to each well of streptavidin-coated black plate (manufactured by PIA...More data for this Ligand-Target Pair
TargetVasopressin V1a/V1b receptor(Homo sapiens (Human))
Central Pharmaceutical Research Institute
Curated by ChEMBL
Central Pharmaceutical Research Institute
Curated by ChEMBL
Affinity DataIC50: 4nMAssay Description:Inhibitory activity against arginine vasopressin V1 receptor using [3H]AVP as radioligand in human plateletMore data for this Ligand-Target Pair
TargetVasopressin V2 receptor(Rattus norvegicus (Rat))
Central Pharmaceutical Research Institute
Curated by ChEMBL
Central Pharmaceutical Research Institute
Curated by ChEMBL
Affinity DataIC50: 4nMAssay Description:Inhibitory activity against arginine vasopressin V2 receptor using [3H]-AVP as radioligand in rat adrenal medullaMore data for this Ligand-Target Pair
Affinity DataIC50: 4nMAssay Description:Inhibitory activity against arginine vasopressin V1 receptor using [3H]AVP as radioligand in rat liverMore data for this Ligand-Target Pair
TargetVirion infectivity factor(Human immunodeficiency virus type 1 group M subtyp...)
Japan Tobacco
US Patent
Japan Tobacco
US Patent
Affinity DataIC50: 4.60nMT: 2°CAssay Description:The donor DNA was diluted with TE buffer to 20 nM, of which 50 μL was added to each well of streptavidin-coated black plate (manufactured by PIA...More data for this Ligand-Target Pair
TargetVirion infectivity factor(Human immunodeficiency virus type 1 group M subtyp...)
Japan Tobacco
US Patent
Japan Tobacco
US Patent
Affinity DataIC50: 4.60nMT: 2°CAssay Description:The donor DNA was diluted with TE buffer to 20 nM, of which 50 μL was added to each well of streptavidin-coated black plate (manufactured by PIA...More data for this Ligand-Target Pair
TargetVirion infectivity factor(Human immunodeficiency virus type 1 group M subtyp...)
Japan Tobacco
US Patent
Japan Tobacco
US Patent
Affinity DataIC50: 4.80nMT: 2°CAssay Description:The donor DNA was diluted with TE buffer to 20 nM, of which 50 μL was added to each well of streptavidin-coated black plate (manufactured by PIA...More data for this Ligand-Target Pair
TargetVirion infectivity factor(Human immunodeficiency virus type 1 group M subtyp...)
Japan Tobacco
US Patent
Japan Tobacco
US Patent
Affinity DataIC50: 4.90nMT: 2°CAssay Description:The donor DNA was diluted with TE buffer to 20 nM, of which 50 μL was added to each well of streptavidin-coated black plate (manufactured by PIA...More data for this Ligand-Target Pair
TargetVasopressin V1a/V1b receptor(Homo sapiens (Human))
Central Pharmaceutical Research Institute
Curated by ChEMBL
Central Pharmaceutical Research Institute
Curated by ChEMBL
Affinity DataIC50: 5nMAssay Description:Inhibitory activity against arginine vasopressin V1 receptor using [3H]AVP as radioligand in human plateletMore data for this Ligand-Target Pair
TargetVasopressin V1a/V1b receptor(Homo sapiens (Human))
Central Pharmaceutical Research Institute
Curated by ChEMBL
Central Pharmaceutical Research Institute
Curated by ChEMBL
Affinity DataIC50: 5nMAssay Description:Inhibitory activity against arginine vasopressin V1 receptor using [3H]AVP as radioligand in human plateletMore data for this Ligand-Target Pair
TargetVirion infectivity factor(Human immunodeficiency virus type 1 group M subtyp...)
Japan Tobacco
US Patent
Japan Tobacco
US Patent
Affinity DataIC50: 5.10nMT: 2°CAssay Description:The donor DNA was diluted with TE buffer to 20 nM, of which 50 μL was added to each well of streptavidin-coated black plate (manufactured by PIA...More data for this Ligand-Target Pair
TargetVirion infectivity factor(Human immunodeficiency virus type 1 group M subtyp...)
Japan Tobacco
US Patent
Japan Tobacco
US Patent
Affinity DataIC50: 5.30nMT: 2°CAssay Description:The donor DNA was diluted with TE buffer to 20 nM, of which 50 μL was added to each well of streptavidin-coated black plate (manufactured by PIA...More data for this Ligand-Target Pair
TargetVirion infectivity factor(Human immunodeficiency virus type 1 group M subtyp...)
Japan Tobacco
US Patent
Japan Tobacco
US Patent
Affinity DataIC50: 5.40nMT: 2°CAssay Description:The donor DNA was diluted with TE buffer to 20 nM, of which 50 μL was added to each well of streptavidin-coated black plate (manufactured by PIA...More data for this Ligand-Target Pair
TargetVirion infectivity factor(Human immunodeficiency virus type 1 group M subtyp...)
Japan Tobacco
US Patent
Japan Tobacco
US Patent
Affinity DataIC50: 5.40nMT: 2°CAssay Description:The donor DNA was diluted with TE buffer to 20 nM, of which 50 μL was added to each well of streptavidin-coated black plate (manufactured by PIA...More data for this Ligand-Target Pair
TargetVirion infectivity factor(Human immunodeficiency virus type 1 group M subtyp...)
Japan Tobacco
US Patent
Japan Tobacco
US Patent
Affinity DataIC50: 5.60nMT: 2°CAssay Description:The donor DNA was diluted with TE buffer to 20 nM, of which 50 μL was added to each well of streptavidin-coated black plate (manufactured by PIA...More data for this Ligand-Target Pair
TargetVirion infectivity factor(Human immunodeficiency virus type 1 group M subtyp...)
Japan Tobacco
US Patent
Japan Tobacco
US Patent
Affinity DataIC50: 5.60nMT: 2°CAssay Description:The donor DNA was diluted with TE buffer to 20 nM, of which 50 μL was added to each well of streptavidin-coated black plate (manufactured by PIA...More data for this Ligand-Target Pair
TargetVirion infectivity factor(Human immunodeficiency virus type 1 group M subtyp...)
Japan Tobacco
US Patent
Japan Tobacco
US Patent
Affinity DataIC50: 5.70nMT: 2°CAssay Description:The donor DNA was diluted with TE buffer to 20 nM, of which 50 μL was added to each well of streptavidin-coated black plate (manufactured by PIA...More data for this Ligand-Target Pair
TargetVirion infectivity factor(Human immunodeficiency virus type 1 group M subtyp...)
Japan Tobacco
US Patent
Japan Tobacco
US Patent
Affinity DataIC50: 5.70nMT: 2°CAssay Description:The donor DNA was diluted with TE buffer to 20 nM, of which 50 μL was added to each well of streptavidin-coated black plate (manufactured by PIA...More data for this Ligand-Target Pair
TargetVirion infectivity factor(Human immunodeficiency virus type 1 group M subtyp...)
Japan Tobacco
US Patent
Japan Tobacco
US Patent
Affinity DataIC50: 5.70nMT: 2°CAssay Description:The donor DNA was diluted with TE buffer to 20 nM, of which 50 μL was added to each well of streptavidin-coated black plate (manufactured by PIA...More data for this Ligand-Target Pair
TargetVirion infectivity factor(Human immunodeficiency virus type 1 group M subtyp...)
Japan Tobacco
US Patent
Japan Tobacco
US Patent
Affinity DataIC50: 5.80nMT: 2°CAssay Description:The donor DNA was diluted with TE buffer to 20 nM, of which 50 μL was added to each well of streptavidin-coated black plate (manufactured by PIA...More data for this Ligand-Target Pair
TargetVirion infectivity factor(Human immunodeficiency virus type 1 group M subtyp...)
Japan Tobacco
US Patent
Japan Tobacco
US Patent
Affinity DataIC50: 5.80nMT: 2°CAssay Description:The donor DNA was diluted with TE buffer to 20 nM, of which 50 μL was added to each well of streptavidin-coated black plate (manufactured by PIA...More data for this Ligand-Target Pair
TargetVirion infectivity factor(Human immunodeficiency virus type 1 group M subtyp...)
Japan Tobacco
US Patent
Japan Tobacco
US Patent
Affinity DataIC50: 5.80nMT: 2°CAssay Description:The donor DNA was diluted with TE buffer to 20 nM, of which 50 μL was added to each well of streptavidin-coated black plate (manufactured by PIA...More data for this Ligand-Target Pair
TargetVirion infectivity factor(Human immunodeficiency virus type 1 group M subtyp...)
Japan Tobacco
US Patent
Japan Tobacco
US Patent
Affinity DataIC50: 5.80nMT: 2°CAssay Description:The donor DNA was diluted with TE buffer to 20 nM, of which 50 μL was added to each well of streptavidin-coated black plate (manufactured by PIA...More data for this Ligand-Target Pair
TargetVirion infectivity factor(Human immunodeficiency virus type 1 group M subtyp...)
Japan Tobacco
US Patent
Japan Tobacco
US Patent
Affinity DataIC50: 5.80nMT: 2°CAssay Description:The donor DNA was diluted with TE buffer to 20 nM, of which 50 μL was added to each well of streptavidin-coated black plate (manufactured by PIA...More data for this Ligand-Target Pair
TargetVirion infectivity factor(Human immunodeficiency virus type 1 group M subtyp...)
Japan Tobacco
US Patent
Japan Tobacco
US Patent
Affinity DataIC50: 5.90nMT: 2°CAssay Description:The donor DNA was diluted with TE buffer to 20 nM, of which 50 μL was added to each well of streptavidin-coated black plate (manufactured by PIA...More data for this Ligand-Target Pair
TargetVirion infectivity factor(Human immunodeficiency virus type 1 group M subtyp...)
Japan Tobacco
US Patent
Japan Tobacco
US Patent
Affinity DataIC50: 5.90nMT: 2°CAssay Description:The donor DNA was diluted with TE buffer to 20 nM, of which 50 μL was added to each well of streptavidin-coated black plate (manufactured by PIA...More data for this Ligand-Target Pair
TargetVirion infectivity factor(Human immunodeficiency virus type 1 group M subtyp...)
Japan Tobacco
US Patent
Japan Tobacco
US Patent
Affinity DataIC50: 5.90nMT: 2°CAssay Description:The donor DNA was diluted with TE buffer to 20 nM, of which 50 μL was added to each well of streptavidin-coated black plate (manufactured by PIA...More data for this Ligand-Target Pair
TargetVirion infectivity factor(Human immunodeficiency virus type 1 group M subtyp...)
Japan Tobacco
US Patent
Japan Tobacco
US Patent
Affinity DataIC50: 5.90nMT: 2°CAssay Description:The donor DNA was diluted with TE buffer to 20 nM, of which 50 μL was added to each well of streptavidin-coated black plate (manufactured by PIA...More data for this Ligand-Target Pair
TargetVirion infectivity factor(Human immunodeficiency virus type 1 group M subtyp...)
Japan Tobacco
US Patent
Japan Tobacco
US Patent
Affinity DataIC50: 5.90nMT: 2°CAssay Description:The donor DNA was diluted with TE buffer to 20 nM, of which 50 μL was added to each well of streptavidin-coated black plate (manufactured by PIA...More data for this Ligand-Target Pair
TargetVirion infectivity factor(Human immunodeficiency virus type 1 group M subtyp...)
Japan Tobacco
US Patent
Japan Tobacco
US Patent
Affinity DataIC50: 5.90nMT: 2°CAssay Description:The donor DNA was diluted with TE buffer to 20 nM, of which 50 μL was added to each well of streptavidin-coated black plate (manufactured by PIA...More data for this Ligand-Target Pair
Affinity DataIC50: 6nMAssay Description:Inhibitory activity against arginine vasopressin V1 receptor using [3H]AVP as radioligand in rat liverMore data for this Ligand-Target Pair
TargetVasopressin V2 receptor(Rattus norvegicus (Rat))
Central Pharmaceutical Research Institute
Curated by ChEMBL
Central Pharmaceutical Research Institute
Curated by ChEMBL
Affinity DataIC50: 6nMAssay Description:Inhibitory activity against arginine vasopressin V2 receptor using [3H]-AVP as radioligand in rat adrenal medullaMore data for this Ligand-Target Pair
TargetVasopressin V2 receptor(Homo sapiens (Human))
Central Pharmaceutical Research Institute
Curated by ChEMBL
Central Pharmaceutical Research Institute
Curated by ChEMBL
Affinity DataIC50: 6nMAssay Description:Inhibitory activity against human recombinant arginine vasopressin V2 receptor using [3H]-AVP as radioligand in CHO cellsMore data for this Ligand-Target Pair
TargetVirion infectivity factor(Human immunodeficiency virus type 1 group M subtyp...)
Japan Tobacco
US Patent
Japan Tobacco
US Patent
Affinity DataIC50: 6nMT: 2°CAssay Description:The donor DNA was diluted with TE buffer to 20 nM, of which 50 μL was added to each well of streptavidin-coated black plate (manufactured by PIA...More data for this Ligand-Target Pair
TargetVirion infectivity factor(Human immunodeficiency virus type 1 group M subtyp...)
Japan Tobacco
US Patent
Japan Tobacco
US Patent
Affinity DataIC50: 6.10nMT: 2°CAssay Description:The donor DNA was diluted with TE buffer to 20 nM, of which 50 μL was added to each well of streptavidin-coated black plate (manufactured by PIA...More data for this Ligand-Target Pair
TargetVirion infectivity factor(Human immunodeficiency virus type 1 group M subtyp...)
Japan Tobacco
US Patent
Japan Tobacco
US Patent
Affinity DataIC50: 6.10nMT: 2°CAssay Description:The donor DNA was diluted with TE buffer to 20 nM, of which 50 μL was added to each well of streptavidin-coated black plate (manufactured by PIA...More data for this Ligand-Target Pair
TargetVirion infectivity factor(Human immunodeficiency virus type 1 group M subtyp...)
Japan Tobacco
US Patent
Japan Tobacco
US Patent
Affinity DataIC50: 6.10nMT: 2°CAssay Description:The donor DNA was diluted with TE buffer to 20 nM, of which 50 μL was added to each well of streptavidin-coated black plate (manufactured by PIA...More data for this Ligand-Target Pair
TargetVirion infectivity factor(Human immunodeficiency virus type 1 group M subtyp...)
Japan Tobacco
US Patent
Japan Tobacco
US Patent
Affinity DataIC50: 6.10nMT: 2°CAssay Description:The donor DNA was diluted with TE buffer to 20 nM, of which 50 μL was added to each well of streptavidin-coated black plate (manufactured by PIA...More data for this Ligand-Target Pair
TargetVirion infectivity factor(Human immunodeficiency virus type 1 group M subtyp...)
Japan Tobacco
US Patent
Japan Tobacco
US Patent
Affinity DataIC50: 6.10nMT: 2°CAssay Description:The donor DNA was diluted with TE buffer to 20 nM, of which 50 μL was added to each well of streptavidin-coated black plate (manufactured by PIA...More data for this Ligand-Target Pair
TargetVirion infectivity factor(Human immunodeficiency virus type 1 group M subtyp...)
Japan Tobacco
US Patent
Japan Tobacco
US Patent
Affinity DataIC50: 6.20nMT: 2°CAssay Description:The donor DNA was diluted with TE buffer to 20 nM, of which 50 μL was added to each well of streptavidin-coated black plate (manufactured by PIA...More data for this Ligand-Target Pair